Drug Profile
Crambescidin 816
Alternative Names: PM 92105Latest Information Update: 10 Jul 2007
Price :
$50
*
At a glance
- Originator PharmaMar
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Oct 2004 This compound is still in active development
- 06 Sep 2002 Crambescidin is still in active development
- 07 Oct 1999 PM 92105 is now called crambescidin 816